MedTrace Logo

Hematological Disorders in Patients With GI Angiodysplasia

NCT07183995 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2025-09-25

No results posted yet for this study

Summary

The aim of this study will be to assess the association between GIT angiodysplasia with any hematological disorders as von Willebrand factor and Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality

Conditions

  • GI Bleeding

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mennat-allah Alaa Abdelgaber · Assiut University

  • Mohamed Zein Elabdin Hafez · Assiut University

  • AbdelHamid Mohamed AbdelHamid · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-08-31
Completion
2027-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07183995 on ClinicalTrials.gov